|Articles|December 14, 2020

Wearable Sensor may Signal COVID-19 Infection

Author(s)Killian Meara

While the number of study participants was too small to extrapolate for the whole population, the authors said they were encouraged.

A recent paper, published in the online journal Scientific Reports, has studied the use of a smart ring in the identification and diagnosis of the coronavirus disease 2019 (COVID-19). The device generates a continuous reading of temperature data which may help to identify a COVID-19 infection even in cases where one is not suspected. The device could potentially be a better illness indicator than a thermometer and could lead to earlier isolation and testing which will aid in curbing the spread of COVID-19.

"Many factors impact body temperature. Single-point temperature measurement is not very meaningful,” Ashley Mason, senior author on the study said. “People go in and out of fever, and a temperature that is clearly elevated for one person may not be a major aberration for another person. Continual temperature information can better identify fever."

The device employed in the study was called the Oura Ring, which is a wearable sensor that pairs to an app on smartphones. The ring continuously measures many different variables like temperature, sleep, wakefulness and heart and respiratory rates. The prospective, observational study involved 3,400 participants who worked in the healthcare industry across the United States, as well as 65,000 others who were invited via the Oura app.

All of the participants in the preliminary study reported that they had been infected with COVID-19 previously and a record of their data was available from before their infection all the way through the end of the study.

The investigators were encouraged, despite the small number of participants, that the smart ring detected illness when symptoms were subtle or unnoticed. Data collected from 50 of the participants found that the device accurately identified higher temperatures in people with COVID-19. While the data on asymptomatic cases is not completely known, the data showed that 38 of the 50 participants had their fever identified when there were no reported symptoms.

"This raises the question of how many asymptomatic cases are truly asymptomatic and how many might just be unnoticed or unreported," Benjamin Smarr, an author on the study said. "By using wearable technology, we're able to query the body directly.”


Related to this article

Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Measles Update: October 9, 2026
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.